Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AEYE | Common Stock | Sale | -$128K | -9.06K | -2.07% | $14.13 | 429K | Aug 9, 2021 | CSB IV US Holdings LLC | F1, F2, F3 |
transaction | AEYE | Common Stock | Sale | -$4.34K | -300 | -0.07% | $14.48 | 429K | Aug 9, 2021 | CSB IV US Holdings LLC | F1, F3, F4 |
holding | AEYE | Common Stock | 18.6K | Aug 9, 2021 | Carr Bettis IRA | F5 | |||||
holding | AEYE | Common Stock | 411K | Aug 9, 2021 | Direct |
Id | Content |
---|---|
F1 | Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2021. |
F2 | Reflects the weighted average price of 9,056 shares of common stock of AudioEye, Inc. sold in multiple transactions on August 9, 2021 with sales prices ranging from $13.46 to $14.4175 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F3 | Dr. Bettis is deemed to be a beneficial owner of CSB IV US Holdings LLC. |
F4 | Reflects the weighted average price of 300 shares of common stock of AudioEye, Inc. sold in multiple transactions on August 9, 2021 with sales prices ranging from $14.46 to $14.52 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F5 | Dr. Bettis is deemed to be a beneficial owner of Carr Bettis IRA. |